| Financial Year |
March 31 2023 |
| Monetary Funds |
4,836,847,144.72 |
| Held-for-trading Financial Assets |
7,197,409.11 |
| Notes Receivable |
18,623,085.71 |
| Accounts Receivable |
1,813,203,743.86 |
| Advances to Suppliers |
118,590,759.74 |
| Other Receivables |
29,361,541.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,697,287,078.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
18,219.90 |
| Other Current Assets |
163,193,835.79 |
| Total Current Assets |
10,133,286,118.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,805,257.34 |
| Long-term Equity Investment |
2,667,732,486.60 |
| Investment Properties |
120,993,710.35 |
| Fixed Assetes |
1,478,673,394.05 |
| Under-construction Projects |
359,618,499.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
752,075,433.97 |
| R&D expenses |
-- |
| Goodwill |
2,423,140,901.05 |
| Long-Term Deferred and Prepaid Expenses |
34,008,155.92 |
| Deferred Income Tax Assets |
88,943,708.41 |
| Other Non-Current Assets |
55,135,830.16 |
| Sub-Total of Non-Current Assets |
8,386,850,899.62 |
| Total Assets |
18,520,137,017.64 |
| Short-Term Loans |
1,079,915,862.29 |
| Trading Financial liabilities |
17,083,935.58 |
| Notes Payable |
18,937,260.30 |
| Accounts Payable |
1,389,310,820.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
175,224,069.79 |
| Taxes Payable |
161,937,846.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,313,713.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
215,187,184.31 |
| Other Current Liabilities |
765,340.36 |
| Sub-Total of Current Liabilities |
3,196,619,981.93 |
| Long-term Loans |
958,201,867.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,248,064.37 |
| Deferred Income Tax Liabilities |
73,520,303.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,378,788,965.63 |
| Total Liabilities |
4,575,408,947.56 |
| Paid-In Capital(Or Share Stock) |
1,202,501,992.00 |
| Capital Surplus |
3,986,846,254.59 |
| Surplus Reserve |
663,843,379.04 |
| LESS:Treasury Stock |
236,625,962.00 |
| Undistributed Profits |
8,004,879,729.30 |
| Minority Stockholder's Interest |
227,609,166.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,717,118,903.73 |
| Owner's Equity（Stockholder's Equity） |
13,944,728,070.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,520,137,017.64 |
